NO306725B1 - Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler - Google Patents

Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler

Info

Publication number
NO306725B1
NO306725B1 NO19965298A NO965298A NO306725B1 NO 306725 B1 NO306725 B1 NO 306725B1 NO 19965298 A NO19965298 A NO 19965298A NO 965298 A NO965298 A NO 965298A NO 306725 B1 NO306725 B1 NO 306725B1
Authority
NO
Norway
Prior art keywords
cdch
drugs
manufacture
compound
preparation
Prior art date
Application number
NO19965298A
Other languages
English (en)
Norwegian (no)
Other versions
NO965298L (no
NO965298D0 (no
Inventor
Alfons Grunenberg
Patrick Borsche
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7779831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO306725(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO965298D0 publication Critical patent/NO965298D0/no
Publication of NO965298L publication Critical patent/NO965298L/no
Publication of NO306725B1 publication Critical patent/NO306725B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19965298A 1995-12-12 1996-12-11 Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler NO306725B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19546249A DE19546249A1 (de) 1995-12-12 1995-12-12 Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (3)

Publication Number Publication Date
NO965298D0 NO965298D0 (no) 1996-12-11
NO965298L NO965298L (no) 1997-06-13
NO306725B1 true NO306725B1 (no) 1999-12-13

Family

ID=7779831

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19965298A NO306725B1 (no) 1995-12-12 1996-12-11 Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler

Country Status (42)

Country Link
US (1) US5849752A (ru)
EP (1) EP0780390B1 (ru)
JP (1) JP4104687B2 (ru)
KR (1) KR100525146B1 (ru)
CN (1) CN1061348C (ru)
AR (1) AR005009A1 (ru)
AT (1) ATE221531T1 (ru)
AU (1) AU708006B2 (ru)
BG (1) BG62258B1 (ru)
BR (1) BR9605968A (ru)
CA (1) CA2192418C (ru)
CO (1) CO4480105A1 (ru)
CU (1) CU22774A3 (ru)
CZ (1) CZ288657B6 (ru)
DE (2) DE19546249A1 (ru)
DK (1) DK0780390T3 (ru)
EE (1) EE03474B1 (ru)
ES (1) ES2179910T3 (ru)
HR (1) HRP960558B1 (ru)
HU (1) HU226521B1 (ru)
ID (1) ID22625A (ru)
IL (1) IL119795A (ru)
IN (1) IN185805B (ru)
MA (1) MA24342A1 (ru)
MY (1) MY117492A (ru)
NL (1) NL300109I1 (ru)
NO (1) NO306725B1 (ru)
NZ (1) NZ299905A (ru)
PL (1) PL184885B1 (ru)
PT (1) PT780390E (ru)
RO (1) RO119782B1 (ru)
RU (1) RU2162468C2 (ru)
SA (1) SA96170492B1 (ru)
SG (1) SG47201A1 (ru)
SI (1) SI0780390T1 (ru)
SK (1) SK282805B6 (ru)
SV (1) SV1996000109A (ru)
TR (1) TR199600970A2 (ru)
TW (1) TW411340B (ru)
UA (1) UA35638C2 (ru)
YU (1) YU49485B (ru)
ZA (1) ZA9610405B (ru)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID24259A (id) * 1997-09-25 2000-07-13 Bayer Ag Formulasi obat yang memiliki pelepasan senyawa aktif terkontrol
DE19751948A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
IL142642A0 (en) * 1998-11-10 2002-03-10 Bayer Ag Pharmaceutical moxifloxacin preparation
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
AU2003278418A1 (en) * 2002-10-31 2004-05-25 Ranbaxy Laboratories Limited Amorphous moxifloxacin hydrochloride
DE602004022646D1 (de) † 2003-04-09 2009-10-01 Reddys Lab Ltd Dr Kristalline form iii von wasserfreiem moxifloxacin-hydrochlorid und ein verfahren zu seiner herstellung
EP1651630A1 (en) * 2003-08-05 2006-05-03 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
WO2005054240A1 (en) * 2003-11-20 2005-06-16 Chemi Spa Polymorphs of 1-cyclopropyl-7-([s,s]-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
DE602007003024D1 (de) 2006-06-27 2009-12-10 Sandoz Ag Neues verfahren zur salzherstellung
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
KR101539561B1 (ko) * 2006-11-13 2015-07-27 씨아이피엘에이 엘티디. 목시플록사신 염산염의 합성방법
EP1992626A1 (en) * 2007-05-10 2008-11-19 Sandoz AG Process for the preparation of moxifloxacin hydrochloride
EP2083010A1 (en) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
TR201106844T2 (tr) 2008-10-09 2012-02-21 Abd� �Brah�M �La� Sanay� Ve T�Caret Anon�M ��Rket�@ Moksi̇floksasi̇n yaş granülasyonunda organi̇k solventleri̇n kullanimi.
WO2010052726A1 (en) * 2008-11-06 2010-05-14 Hetero Research Foundation Novel polymorph of moxifloxacin hydrochloride
WO2010066385A1 (de) 2008-12-08 2010-06-17 Ratiopharm Gmbh Kompaktiertes moxifloxacin
EA201101564A1 (ru) 2009-05-15 2012-07-30 Редкс Фарма Лимитед Редокс производные лекарственных средств
WO2011121596A2 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Crystal modification of moxifloxacin hydrochloride
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
US9388178B2 (en) 2012-12-04 2016-07-12 Mankind Research Centre Process for the preparation of moxifloxacin hydrochloride
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
CA2904387C (en) 2013-03-15 2021-12-07 Melinta Therapeutics, Inc. Methods of treating infections in overweight and obese patients using antibiotics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
CN1019114B (zh) * 1986-03-31 1992-11-18 三共株式会社 喹啉-3-羟酸衍生物的制备方法
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
TW209865B (ru) 1992-01-10 1993-07-21 Bayer Ag
WO1993015070A1 (en) * 1992-01-31 1993-08-05 Chugai Seiyaku Kabushiki Kaisha Crystal of quinolonecarboxylic acid derivative hydrate
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
NO301165B1 (no) * 1992-12-25 1997-09-22 Daiichi Seiyaku Co Bicykliske aminderivater og antibakterielle midler inneholdende disse
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
EP0676199B1 (en) * 1994-04-07 1998-09-02 Pfizer Inc. Use of trovafloxacin or derivatives thereof for the manufacture of a medicament for the treatment of H. pylori infections

Also Published As

Publication number Publication date
TW411340B (en) 2000-11-11
NO965298L (no) 1997-06-13
CN1160052A (zh) 1997-09-24
HRP960558A2 (en) 1998-02-28
IL119795A (en) 1998-12-27
SG47201A1 (en) 1998-03-20
ATE221531T1 (de) 2002-08-15
ZA9610405B (en) 1997-06-23
PL184885B1 (pl) 2003-01-31
DK0780390T3 (da) 2002-11-11
RU2162468C2 (ru) 2001-01-27
EP0780390B1 (de) 2002-07-31
NZ299905A (en) 1998-09-24
ID22625A (id) 1999-12-02
SK282805B6 (sk) 2002-12-03
UA35638C2 (ru) 2001-04-16
MX9606325A (es) 1997-10-31
HUP9603428A2 (en) 1997-08-28
CU22774A3 (es) 2002-07-24
HU9603428D0 (en) 1997-01-28
US5849752A (en) 1998-12-15
CA2192418C (en) 2001-06-12
MY117492A (en) 2004-07-31
EE03474B1 (et) 2001-08-15
SV1996000109A (es) 1997-10-23
NO965298D0 (no) 1996-12-11
IN185805B (ru) 2001-05-05
DE59609501D1 (de) 2002-09-05
CZ364696A3 (en) 1997-07-16
JP4104687B2 (ja) 2008-06-18
CZ288657B6 (cs) 2001-08-15
BR9605968A (pt) 1998-08-18
BG62258B1 (bg) 1999-06-30
JPH09169757A (ja) 1997-06-30
TR199600970A2 (tr) 1997-06-21
SA96170492B1 (ar) 2006-05-23
AU708006B2 (en) 1999-07-29
EE9600201A (et) 1997-06-16
SI0780390T1 (en) 2002-10-31
EP0780390A1 (de) 1997-06-25
SK159196A3 (en) 1997-10-08
BG101043A (en) 1998-04-30
YU49485B (sh) 2006-08-17
AR005009A1 (es) 1999-04-07
ES2179910T3 (es) 2003-02-01
YU65096A (sh) 1998-12-23
DE19546249A1 (de) 1997-06-19
HU226521B1 (en) 2009-03-30
HRP960558B1 (en) 2002-04-30
PT780390E (pt) 2002-11-29
AU7421696A (en) 1997-06-19
MA24342A1 (fr) 1998-07-01
HUP9603428A3 (en) 1997-10-28
RO119782B1 (ro) 2005-03-30
NL300109I1 (nl) 2003-02-03
CA2192418A1 (en) 1997-06-13
KR970042550A (ko) 1997-07-24
KR100525146B1 (ko) 2006-01-27
PL317415A1 (en) 1997-06-23
CO4480105A1 (es) 1997-07-09
IL119795A0 (en) 1997-03-18
CN1061348C (zh) 2001-01-31

Similar Documents

Publication Publication Date Title
NO306725B1 (no) Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler
NO308107B1 (no) Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
DK0807111T3 (da) Substituerede heterocykliske forbindelser, fremgangsmåde til fremstillingen heraf samt farmaceutiske sammensætninger indeholdende disse
NO965377D0 (no) Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene
NO308798B1 (no) Proteinkinase-C-hemmere, anvendelse av samme for fremstilling av farmasøytika samt farmasøytisk formulering omfattende samme
FI954767A (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
NO307340B1 (no) Krystallinsk hydroklorid av (R)-(-)-2-{N-[4-(1,1-dioksido-3- okso-2,3-dihydro-benzisotiazol-2-yl)-butyl]-aminometyl}-kroman, legemiddel inneholdende samme, samt fremstilling og anvendelse av samme
HUP9802270A3 (en) Aryl glycinamide derivatives, methods of producing these substances, pharmaceutical compositions containing such compounds and their use
NO179359C (no) Fremgangsmåte for fremstilling av farmasöytisk preparat inneholdende somatostatinanaloger.
NO306347B1 (no) Eleutherobin og analoger av denne, anvendelse av forbindelsen samt farmasöytisk preparat inneholdende denne
DK102990D0 (da) Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
PT87535A (pt) Process for the preparation of novel anf peptide derivatives and of pharmaceutical compositions containing the same
EE03803B1 (et) a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid
HUP9702448A2 (hu) Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
NO960529L (no) Substituerte benzensulfonylureaer og -tioureaer, fremgangsmåte for fremstilling av disse, og deres anvendelse for fremstilling av farmasöytiske preparater samt farmasöytiske preparater inneholdende forbindelsene
NO305836B1 (no) Oksazolidin-2-on-forbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler
NO981537L (no) FremgangsmÕte for fremstilling av antimalariamedikamenter
NO305560B1 (no) Krystallinsk 3-(4-heksyloksy-1,2,5-tiadiazol-3-yl)-1,2,5,6-tetrahydro-1-metylpyridin-(+)-L-hydrogentartrat, farmas°ytiske preparater som omfatter forbindelsen, samt anvendelse av forbindelsen til fremstilling av et medikament
BR9610851A (pt) Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto
DK0727417T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og anvendelse af farmaceutiske præparater på grundlag af disse forbindelser samt lægemidler, der indeholder dem
PT86925A (pt) Process for the preparation of imidazodiazepine derivatives and of pharmaceutical compositions containing the same
PT87079A (pt) Process for the preparation of dopamine-beta-hydroxylase inhibitors and of pharmaceutical compounds containing them
NO305834B1 (no) 4-merkaptobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MK1K Patent expired